期刊文献+

非糖尿病、非肥胖患者胰岛素敏感性与冠状动脉病变严重程度的相关性分析 被引量:2

Correlation of severity of coronary artery disease with insulin sensitivity in non-diabetic and non-obese patients
下载PDF
导出
摘要 目的:探讨非糖尿病、非肥胖患者胰岛素敏感性与冠状动脉疾病严重程度的相关性。方法:连续入选自2013年3月至2014年3月,因胸闷、胸痛症状入院接受冠状动脉造影的非糖尿病、非肥胖患者483例。根据稳态模型胰岛素抵抗指数(HOMA-IR)定义胰岛素抵抗(IR)组(n=118)和胰岛素敏感组(n=365)。通过冠状动脉造影确定的病变血管数目和SYNTAX积分评价冠状动脉病变的广泛性和严重程度。结果:IR患者年龄偏小[(57.1±10.4)vs.(59.5±9.4)岁,P=0.02]、平均BMI水平高[(27.1±2.8)vs.(25.1±2.8),P=0.001]、高血压(72.9%vs.57.5%,P=0.03)和超质量(76.3%vs.50.7%,P=0.00)发生率高。IR患者冠状动脉无病变比例低(14.4%vs.23.3%,P=0.04),2支或以上血管病变比例高(50%vs.36.7%,P=0.01),平均SYNTAX积分[8(5,15)vs.7(2,12)]以及SYNTAX积分高分组(SYNTAX≥10)的比例增高,差异有统计学意义。在控制多种冠心病传统危险因素后,偏相关分析显示HOMA-IR与病变血管数目(r=0.23,P=0.00)、SYNTAX积分(r=0.20,P=0.01)、支架数目(r=0.17,P=0.02)呈正相关。结论:在非糖尿病、非肥胖患者,胰岛素敏感性下降与冠状动脉病变的广泛性和严重性密切相关,可以作为识别高危患者的工具;改善IR状态可以作为冠状动脉疾病治疗策略的新靶点。 Objective:Insulin sensitivity decreased or insulin resistance (IR) has known to be associated with coronary artery disease ( CAD), but the assessment of severity of the CAD based on IR in non-diabetes mellitus has not been established in detail. The aim of our study was to investigate the correlation between Insulin sensitivity and the severity of angiographic characteristics of coronary atherosclerosis in non-diabetic and nonobese patients. Methods: 483 consecutive nondiabetic and non-obese patients who underwent coronary angiography for the evaluation of CAD were recruited from March 2013 to March 2014. The patients were divided into insulin resistant ( HOMA-IR ≥2. 84, n = 118 ) and insulin sensitivity ( IS, HOMA-IR 〈 2. 84, n = 365 ) according to the homeostasis model assessment insulin resistance index( HOMA-IR). The number of diseased coronary artery and angiographic characteristics of coronary atherosclerosis defined by SYNTAX score were used to evaluate the extent and severity of coronary artery. Results: Compared with IS patients, the patients with IR were younger and had significantly ( P 〈 0. 05 ) higher values of BMI, TG, fasting blood glucose, fasting plasma insulin, fasting C-peptide, UA, hsCRP and HOMA IR. The percent of hypertension(72. 9% vs. 57.5% ,P =0. 03 ), overweight (76. 3 % vs. 50. 7 % , P = 0. 00) and multi-vessel lesion (50% vs. 36. 7 % , P = 0. 01 ) were also higher than IS. After adjusting many traditional risk factors of coronary heart disease including TC, HDL- C, current smoking and hypertension, there was a significant correlation between HOMA-IR and number of dis- eased coronary arteries ( r = 0. 23, P = 0. 00) , SYNTAX score ( ( r = 0. 20, P = 0. 01 ) and number of stents ( r = 0. 17,P = 0. 02). Logistic regression analysis show smoking ( OR = 1.86, P = 0. 02 ) and TC ( OR = 1.25, P = 0.04) are the independent risk factor of CAD. Coneluslon: IR was associated with the extent and severity of CAD as measured by both the number of diseased coronary arteries and SYNTAX score in non-diabetic and nonobese patients. Cardiologist might able to identify the high risk patients by measure of IR and it might be a new target for prevent coronary atheroselerosis.
出处 《心肺血管病杂志》 CAS 2014年第6期774-778,共5页 Journal of Cardiovascular and Pulmonary Diseases
基金 北京市卫生系统高层次卫生技术人才队伍建设专项经费(2011-1-5) 北京市医院管理局临床医学发展专项经费(ZY201303) 国家临床重点专科建设项目
关键词 非糖尿病 胰岛素敏感性 SYNTAX积分 冠状动脉疾病 Non-diabetic Insulin sensitivity SYNTAX score Coronary artery disease
  • 相关文献

参考文献24

  • 1Young MH,Jeng CY,Sheu WH,et al.Insulin resistance,glucose intolerance,hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease.Am J Cardiol,1993,72:458-460.
  • 2Shinozaki K,Suzuki M,Ikebuchi M,et al.Demonstration of insulin resistance in coronary artery disease documented with angiography.Diabetes Care,1996,19:1-7.
  • 3Srikanth S,Deedwania P.Management of coronary artery disease in patients with type 2 diabetes mellitus.Curr Cardiol Rep,2007,9:264-271.
  • 4An X,Yu D,Zhang R,et al.Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease:A one-year follow-up study.Cardiovasc Diabetol,2012,11:71.
  • 5Yun KH,Jeong MH,Kim KH,et al.The effect of insulin resistance on prognosis of non-diabetic patients who underwent percutaneous coronary intervention.J Korean Med Sci,2006,21:212-216.
  • 6Kitta Y,Nakamura T,Uematsu M,et al.Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors.J Cardiol,2013,62:348-353.
  • 7Eddy D,Schlessinger L,Kahn R,et al.Relationship of insulin resistance and related metabolic variables to coronary artery disease:A mathematical analysis.Diabetes Care,2009,32:361-366.
  • 8Srinivasan MP,Kamath PK,Manjrekar PA,et al.Correlation of severity of coronary artery disease with insulin resistance.North Am J Med Scien,2013,5:611-614.
  • 9Wallace TM,Levy JC,Matthews DR.Use and abuse of homa modeling.Diabetes Care,2004,27:1487-1495.
  • 10Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,1985,28:412-419.

二级参考文献22

  • 1Martin JF, Shaw T, Heggie J, et al. Measurement of the density of human platelets and its relationship to volume. Br J Haematol 1983,54:337-352.
  • 2Tschoepe D, Roesen P, Kaufmann L, et al. Evidence for abnor- mal platelet glycoprotein expression in diabetes mellitus. Eur J C/in Invest, 1990,20 : 166-170.
  • 3Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets, 2006, 17 : 67- 69.
  • 4Slavka G, Perkmann T, Haslacher H, et al. Mean platelet vol- ume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thremb Vasc Biol, 2011,31:1215-1218.
  • 5Yang A, Pizzulli L, Luderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 2006,117:371-377.
  • 6Deveci E, Yesil M, Akinci B, et al. Evaluation of insulin resist- ance in normoglycemic patients with coronary artery disease. Clin Cardiol, 2009,32:32-36.
  • 7Kim J, Chae YK, Chemoff A. The Risk for Coronary Heart Dis-ease According to Insulin Resistance with and without Type 2 Di- abetes. Endocr Res,2013,38 : 195-205.
  • 8Anfossi G, Russo I, Trovati M. Platelet dysfunction in central o- besity. Nutr Metab Cardiovasc Dis, 2009,19:440-449.
  • 9Onat A, Hergenc G, Turkmen S, et al. Discordance between in- sulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Me- tabolism, 2006,55:445-452.
  • 10Pereg D, Berlin T, Mosseri M. Mean platelet volume on admis- sion correlates with impaired response to thrombolysis in patients with ST-elevation myocardial infarction. Platelets, 2010,21 : 117 - 121.

共引文献8

同被引文献31

  • 1Srinivasan MP, Kamath PK, Manjrekar PA, et al. Correlation of severity of coronary artery disease with insulin resistance. N Am J Med Sci,2013,5 : 611-614.
  • 2Karrowni W, Li Y, Jones PG, et al. Insulin resistance is associ- ated with significant clinical atherosclerosis in nondiabetic pa- tients with acute myocardial infarction. Arterioscler Thromb Vasc Biol,2013,33:2245-2251.
  • 3Sinha DP, Ahmed S, Baneerjee AK, et al. Significance of an in- dex of insulin resistance in non-diabetic patients with impaired fasting glucose with acute myocardial infarction and its correlation to short term outcome. Indian Heart J, 2009,61:40-43.
  • 4Caccamo G, Bonura F, Vitale G, et al. Insulin resistance and a- cute coronary syndrome. Atherosclerosis, 2010,211:6724575.
  • 5Radke PW, Voswinkel M, Reith M, et al. Relation of fasting in- sulin plasma levels to restenosis after elective coronary stent im- plantation in patients without diabetes mellitus. Am J Cardiol, 2004,93:639-641.
  • 6Yun KH, Jeong MH, Kim KH, et al. The effect of insulin resistance on prognosis of non-diabetic patients who underwent percutaneons coronary intervention. J Korean Med Sci, 2006,21:212-216.
  • 7Uetani T, Amano T, Harada K, et al. Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents. JACC Cardiovasc Interv ,2012,5 : 1159-1167.
  • 8Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/ AHA/AATS/PCNAZSCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology/A- merican heart association task force on practice guidelines, and the American association for thoracic surgery, preventive cardio- vascular nurses association, society for cardiovascular angiogra- phy and interventions, and society of thoracic surgeons. J Am Coil Cardiol, 2014,4 : 1929-1949.
  • 9Navarese EP, Buffon A, Andreotti F, et al. Meta-analysis of im- pact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol,2013,11 : 1123-1130.
  • 10Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes care, 2004,27:1487-1495.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部